Recombinant 2019-nCoV S1 Protein (Active)

Quantity:

Products_type

Recombinant Protein
Products_short_name

[COVID 19 S1 Coronavirus]
Products_name_syn

[2019 Novel Coronavirus; Coronavirus; CoV; COVID-19 virus; HCoV-2; Human Coronavirus 2019; SARS2; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; S1, S1 protein; 2019-nCoV S1 protein; Coronavirus S1 protein; cov S1 Protein]
Products_gene_name

[COVID-19]
Products_gene_name_syn

[2019-nCoV; SARS-CoV-2; SARS coronavirus 2 proteome; COVID19; SARS-CoV2[Similar Products]]
Purity

>85% as determined by reducing SDS-PAGE.
Form

Supplied as a 0.2um filtered solution of PBS, pH7.4
Storage_stability

Ships on dry ice. Reconstituted protein solution should be stored at
Tested_application

Functional Assay
Source

Recombinants or rec. proteins
Group

recombinants

Gene target

2019-nCoV Protein Active
Short name

Recombinant 2019-nCoV S1 Protein (Active)
Technique

Recombinant, E. coli recombinant proteins are genetic recombinations in Escherichia coli, supplied as white sterile powder lyopillized. MyBioSource advises they will be reconstituted in a buffer soluion or culture medium for cell culture.
Host

Baculovirus-Insect Cells
Alternative name

Rec. 2019-nCoV S1 Protein (functionnal)
Alternative technique

rec

Quantity:

Name

Primary Cell Culture
Concept

Scope note: The initial culturing of cells derived directly from fresh TISSUES.
Tree numbers
- E01.370.225.500.223.500
- E05.200.500.265.500
- E05.242.223.500
- E05.481.500.249.500
Qualifiers

ethics, trends, veterinary, history, classification, economics, instrumentation, methods, standards, statistics & numerical data